Citation:Li C, Sun Y, Pan Y, Wang Q, Yang S, Chen H 2010

Citation

Li C, Sun Y, Pan Y, Wang Q, Yang S, Chen H. Gemcitabine plus paclitaxel versus carboplatin plus either gemcitabine or paclitaxel in advanced non-small-cell lung cancer: a literature-based meta-analysis. Lung 2010 Oct;188(5):359-64 Available from: http://www.ncbi.nlm.nih.gov/pubmed/20703493.

Critical appraisals

• Assign a critical appraisal

Critical appraisal link	Clinical question	Assigned to	Status
Li C, Sun Y, Pan Y, Wang Q, Yang S, Chen H 2010	What is the optimal systemic therapy for stage IV inoperable NSCLC?	Assoc. Prof. Nick Pavlakis	completed
Li C, Sun Y, Pan Y, Wang Q, Yang S, Chen H 2010 2	Which new agent or platinum combination regimen is best for treatment of stage IV inoperable NSCLC?	Assoc. Prof. Nick Pavlakis	completed

Compare quality appraisals for each clinical question

• [[Clinical question:What is the optimal systemic therapy for stage IV inoperable NSCLC?|]] (compare critical appraisals)
• [[Clinical question:Which new agent or platinum combination regimen is best for treatment of stage IV inoperable NSCLC?|]] (compare critical appraisals)

Cited by

1. Are non-platinum doublet chemotherapy regimens as effective as platinum doublet regimens for treatment of stage IV inoperable NSCLC?
2. What is the optimal systemic therapy for stage IV inoperable NSCLC?